Using MIST With or Without EMD in Treatment of Intrabony Periodontal Defects.
Periodontal Minimally Invasive Surgical Techniques With or Without Enamel Matrix Derivative Gel for Treatment of Intrabony Periodontal Osseous Defects in Humans.
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
After performing the power calculation, healthy adult participants for the study will be randomly allocated into two groups. The intervention group will receive minimally invasive surgical techniques (MIST) with enamel matrix derivative (Emdogain) as a treatment of intrabony periodontal defect. The control group will receive minimally invasive surgical techniques (MIST) without enamel matrix derivative (Emdogain). Clinical attachment level (CAL) gain and periodontal pocket depth (PPD) reduction as well as the position of gingival margin (REC) as the main outcomes and the radiographic intrabony infill, bleeding on probing (BoP), full mouth plaque score (FMPS) and full mouth bleeding score (FMBS) as secondary outcome will be recorded for the participants by 3 examiners at three stages:
- 1.Before the procedure as a baseline record.
- 2.6 months after surgery, all parameters EXCEPT intra oral periapical (PA) radiographs.
- 3.12 months after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2016
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 20, 2016
CompletedFirst Posted
Study publicly available on registry
June 22, 2016
CompletedStudy Start
First participant enrolled
September 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedJune 28, 2016
June 1, 2016
1.8 years
June 20, 2016
June 27, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
clinical attachment level gain CAL
periodontal clinical attachment level gain
12 months
Secondary Outcomes (5)
radiographic bone fill
12 months
full mouth bleeding score FMBS
12 months
full mouth dental plaque score FMPS
12 months
periodontal probing depth reduction PPD
12 months
marginal gingival recession REC
12 months
Study Arms (2)
Control Group (MIST without EMD)
SHAM COMPARATORThose participants who will receive the minimally invasive surgical techniques but without application Enamel Matrix Derivative (EMD) .
Test Group (MIST with EMD)
EXPERIMENTALThose participant who will receive the minimally invasive surgical techniques with the application of Enamel Matrix Derivative (EMD) .
Interventions
Using minimally invasive surgical techniques.
Use of enamel matrix derivative for the treatment of intrabony periodontal defects.
Eligibility Criteria
You may qualify if:
- Candidate from both gender males and females with moderate to advanced periodontal disease.
- years old and more.
- Probing pocket depth (PPD) of \> 5mm and clinical attachment loss (CAL) of \>6mm.
- and 3-wall angular intra bony periodontal defects.
- Full-mouth plaque score (FMPS) of \< 20%.
- Full-mouth bleeding score (FMBS) of \< 15%.
- Medically fit and healthy.
- Not allergic to any materials or medications that could be used during or after the procedure.
You may not qualify if:
- Patients with diabetes and any haematological disorders that might compromise the procedure.
- wall and crater defects.
- Immunocompromised patients and those with known allergy to one of the materials or medications to be used.
- Patients whose FMPS \> 20%.
- Smokers.
- Pregnant women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- STUDY DIRECTOR
Kevin G Seymour
The University of Manchester
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
June 20, 2016
First Posted
June 22, 2016
Study Start
September 1, 2016
Primary Completion
July 1, 2018
Study Completion
August 1, 2018
Last Updated
June 28, 2016
Record last verified: 2016-06
Data Sharing
- IPD Sharing
- Will not share
Individual Participant data will not be shared however once anonymised the results may be published.